Cargando…
Dupilumab: a new contestant to corticosteroid in allergic bronchopulmonary aspergillosis
Allergic bronchopulmonary aspergillosis (ABPA) is a disease characterized by severe disability with recurrent wheezing and shortness of breath. The current recommended therapy is daily oral corticosteroids +/− oral antifungal therapy. Despite this, many patients continue to have severe symptoms, and...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081018/ https://www.ncbi.nlm.nih.gov/pubmed/33948179 http://dx.doi.org/10.1093/omcr/omaa029 |